Selenite benefits embryonic stem cells therapy in Parkinson's disease

Current Molecular Medicine

Volumn 12, Issue 8, 2012, Pages 1005-1014

  Tian, L P ^a   Zhang, S ^a   Xu, L ^a   Li, W ^a   Wang, Y ^a   Chen, S D ^a   Ding, J Q ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cells transplantation; Dopaminergic neurons; Embryonic stem cells; Inflammation; Parkinson's disease; Selenite

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; SODIUM SELENITE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARKINSON DISEASE; STEM CELL TRANSPLANTATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CORPUS STRIATUM; CULTURE MEDIA, SERUM-FREE; CYCLOOXYGENASE 2; DOPAMINERGIC NEURONS; EMBRYONIC STEM CELLS; GRAFT SURVIVAL; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; SODIUM SELENITE; TRANSPLANTATION TOLERANCE; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 84866557361     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/156652412802480880     Document Type: Article

References (45)

1. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet 2004; 363: 1783-93.
2. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-9.
3. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54: 403-14.
4. Kawasaki H, Mizuseki K, Nishikawa S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28: 31-40.
5. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000; 18: 675-9.
6. Kim DW, Chung S, Hwang M, et al. Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells 2006; 24: 557-67.
7. Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002; 418: 50-6.
8. Park CH, Minn YK, Lee JY, et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 2005; 92: 1265-76.
9. Danielyan L, Schafer R, von Ameln-Mayerhofer A, et al. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res 2011; 14: 3-16.
10. Morizane A, Takahashi J, Takagi Y, Sasai Y, Hashimoto N. Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cellderived inducing activity. J Neurosci Res 2002; 69: 934-9.
11. Inden M, Kim DH, Qi M, et al. Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats. Neurosci Lett 2005; 387: 151-6.
12. Duan WM, Zhao LR, Westerman M, et al. Enhancement of nigral graft survival in rat brain with the systemic administration of synthetic fibronectin peptide V. Neuroscience 2000; 100: 521-30.
13. Inden M, Kim D, Gu Y, et al. Pharmacological characteristics of rotational behavior in hemiparkinsonian rats transplanted with mouse embryonic stem cell-derived neurons. J Pharmacol Sci 2004; 96: 53-64.
14. Zawada WM, Zastrow DJ, Clarkson ED, Adams FS, Bell KP, Freed CR. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res 1998; 786: 96-103.
15. Sortwell CE, Pitzer MR, Collier TJ. Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Exp Neurol 2000; 165: 268-77.
16. Emgard M, Hallin U, Karlsson J, Bahr BA, Brundin P, Blomgren K. Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J Neurochem 2003; 86: 1223-32.
17. Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease. Brain Res 2009; 1276: 39-49.
18. Sortwell CE. Strategies for the augmentation of grafted dopamine neuron survival. Front Biosci 2003; 8: s522-32.
19. Sortwell CE, Camargo MD, Pitzer MR, Gyawali S, Collier TJ. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp Neurol 2001; 169: 23-9.
20. Johann V, Schiefer J, Sass C, et al. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Exp Brain Res 2007; 177: 458-70.
21. Mazurova Y, Latr I, Osterreicher J, Guncova I. Progressive reparative gliosis in aged hosts and interferences with neural grafts in an animal model of Huntington's disease. Cell Mol Neurobiol 2006; 26: 1423-41.
22. Imam SZ, Newport GD, Islam F, Slikker W, Jr., Ali SF. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res 1999; 818: 575-8.
23. Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S, Islam F. Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Neurochem 2003; 84: 438-46.
24. Prabhu KS, Zamamiri-Davis F, Stewart JB, Thompson JT, Sordillo LM, Reddy CC. Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-kappaB in up-regulation. Biochem J 2002; 366: 203-9.
25. Kim IY, Stadtman TC. Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc Natl Acad Sci U S A 1997; 94: 12904-7.
26. Kim SH, Johnson VJ, Shin TY, Sharma RP. Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-kappaB signaling pathways. Exp Biol Med (Maywood) 2004; 229: 203-13.
27. Shimohashi N, Nakamuta M, Uchimura K, et al. Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of jun-N-terminal kinase and the NF-kappab signaling pathway in rat Kupffer cells. J Cell Biochem 2000; 78: 595-606.
28. Gundry RL, Tchernyshyov I, Sheng S, et al. Expanding the mouse embryonic stem cell proteome: combining three proteomic approaches. Proteomics 2010; 10: 2728-32.
29. Dolmazon V, Alenina N, Markossian S, et al. Forced expression of LIM homeodomain transcription factor 1b enhances differentiation of mouse embryonic stem cells into serotonergic neurons. Stem Cells Dev 2011; 20: 301-11.
30. Ying QL, Smith AG. Defined conditions for neural commitment and differentiation. Methods Enzymol 2003; 365: 327-41.
31. Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003; 21: 183-6.
32. Pan J, Zhao YX, Wang ZQ, Jin L, Sun ZK, Chen SD. Expression of FasL and its interaction with Fas are mediated by c-Jun N-terminal kinase (JNK) pathway in 6-OHDAinduced rat model of Parkinson disease. Neurosci Lett 2007; 428: 82-7.
33. Ben-Hur T, Idelson M, Khaner H, et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 2004; 22: 1246-55.
34. Yurek DM, Flectcher AM, Kowalczyk TH, Padegimas L, Cooper MJ. Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons. Cell Transplant 2009; 18: 1183-96.
35. Gao HM, Hong JS, Zhang W, Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 2002; 22: 782-90.
36. Elkabetz Y, Panagiotakos G, Al Shamy G, Socci ND, Tabar V, Studer L. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 2008; 22: 152-65.
37. Zhang R, Xu S, Cai Y, Zhou M, Zuo X, Chan P. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration Through Inhibition of Microglial Activation. Evid Based Complement Alternat Med 2011; 2011: 156810.
38. Brown GC, Neher JJ. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010; 41: 242-7.
39. Brown GC. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 2007; 35: 1119-21.
40. Broom L, Marinova-Mutafchieva L, Sadeghian M, Davis JB, Medhurst AD, Dexter DT. Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease. Free Radic Biol Med 2011; 50: 633-40.
41. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000; 18: 399-404.
42. Qian L, Flood PM, Hong JS. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm 2010; 117: 971-9.
43. Qin L, Liu Y, Wang T, et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 2004; 279: 1415-21.
44. Shibata H, Katsuki H, Nishiwaki M, Kume T, Kaneko S, Akaike A. Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: role of inducible nitric oxide synthase and protection by indomethacin. J Neurochem 2003; 86: 1201-12.
45. Park HY, Han MH, Park C, et al. Anti-inflammatory effects of fucoidan through inhibition of NF-kappaB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells. Food Chem Toxicol 2011; 49: 1745-52.